MARKET

SRGA

SRGA

RTI Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.310
-0.070
-5.07%
Closed 19:34 09/20 EDT
OPEN
1.370
PREV CLOSE
1.380
HIGH
1.415
LOW
1.300
VOLUME
3.82M
TURNOVER
--
52 WEEK HIGH
3.270
52 WEEK LOW
0.8825
MARKET CAP
182.63M
P/E (TTM)
-0.6199
1D
5D
1M
3M
1Y
5Y
BRIEF-Surgalign Holdings Inc Says Effective Sept. 10, 2021, Stuart Simpson Resigned As Chairman Of The Board
reuters.com · 5d ago
BRIEF-Surgalign Appoints Sheryl Conley As Chair Of The Board Of Directors
reuters.com · 5d ago
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DEERFIELD, Ill., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that it has granted restric...
GlobeNewswire · 09/07 20:30
Trillium Therapeutics, Vivos Therapeutics leads healthcare gainers; Flora Growth, Surgalign among major losers
Gainers: Trillium Therapeutics TRIL +187%, Vivos Therapeutics VVOS +57%, Xeris Pharmaceuticals XERS +19%, ALX Oncology (NASDAQ:ALXO) +24%, Candel Therapeutics (NASDAQ:CADL) +20%. Losers: Flora Growth (NASDAQ:FLGC) -10%, Surgalign (NASDAQ:SRGA) -9%, Alimera...
Seekingalpha · 08/23 15:05
Do Options Traders Know Something About Surgalign Holdings (SRGA) Stock We Don't?
Investors need to pay close attention to Surgalign Holdings (SRGA) stock based on the movements in the options market lately.
Zacks · 08/23 12:40
President Terry Rich Just Bought 98% More Shares In Surgalign Holdings, Inc. (NASDAQ:SRGA)
Those following along with Surgalign Holdings, Inc. ( NASDAQ:SRGA ) will no doubt be intrigued by the recent purchase...
Simply Wall St. · 08/20 14:25
BRIEF-Surgalign Announces Issuance Of U.S. Patent Covering The Use Of Artificial Intelligence In Medical Image Segmentation
reuters.com · 08/19 13:12
Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation
The machine learning system is part of HOLO AI™, Surgalign’s core technology in artificial intelligence and augmented realityDEERFIELD, Ill., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company foc...
GlobeNewswire · 08/19 13:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRGA. Analyze the recent business situations of RTI Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRGA stock price target is 3.357 with a high estimate of 4.000 and a low estimate of 2.500.
EPS
Institutional Holdings
Institutions: 144
Institutional Holdings: 60.78M
% Owned: 43.60%
Shares Outstanding: 139.41M
TypeInstitutionsShares
Increased
21
12.85M
New
20
5.34M
Decreased
33
14.01M
Sold Out
36
6.25M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.59%
Key Executives
Non-Executive Chairman
Sheryl Conley
President/Chief Executive Officer/Director
Terry Rich
Chief Financial Officer/Chief Operating Officer
Jonathon Singer
General Counsel/Secretary
Joshua DeRienzis
Other
Scott Durall
Lead Director/Independent Director
Mark Stolper
Director
Pawel Lewicki
Independent Director
Thomas McEachin
Independent Director
Paul Thomas
Independent Director
Nicholas Valeriani
No Data
About SRGA
RTI Surgical Holdings, Inc. is a surgical implant company. The Company designs, develops, manufactures and distributes biologic, metal and synthetic implants. The Company's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. It operates in one reportable segment composed of lines of business, including spine, sports and international. The Company manufactures metal and synthetic implants and processes donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using its BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes. The Company's implants are distributed directly to hospitals throughout the United States and in over 50 countries worldwide. It also owns augmented reality and artificial intelligence (ARAI) digital surgery platform.

Webull offers kinds of Surgalign Holdings Inc stock information, including NASDAQ:SRGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRGA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRGA stock methods without spending real money on the virtual paper trading platform.